Several studies have shown that effector T cells in the gut mucosa of patients with CD and those with CD with coexisting T1D might be insensitive to FOXP3+ Tregs because of the high level of IL-15 [14, 37]. This evidence concerns the gene IL15 and type 1 diabetes mellitus.